PNC Financial Services Group’s Immuneering IMRX Stock Holding History

PNC Financial Services Group’s Portfolio IMRX Stock Details IMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$105K	Hold	20,000	–	–	﹤0.01%	2783
2025 Q4	$132K	Hold	20,000	–	–	﹤0.01%	2621
2025 Q3	$140K	Hold	20,000	–	–	﹤0.01%	2556
2025 Q2	$67.4K	Hold	20,000	–	–	﹤0.01%	2948
2025 Q1	$30.4K	Hold	20,000	–	–	﹤0.01%	3359
2024 Q4	$44K	Hold	20,000	–	–	﹤0.01%	3168
2024 Q3	$49.8K	Sell	20,000 -106	-0.5%	-$154	﹤0.01%	3093
2024 Q2	$25.7K	Buy	20,106 +106	+0.5%	+$174	﹤0.01%	3355
2024 Q1	$57.8K	Hold	20,000	–	–	﹤0.01%	2924
2023 Q4	$147K	Hold	20,000	–	–	﹤0.01%	2367
2023 Q3	$154K	Buy	+20,000	New	+$184K	﹤0.01%	2305

Other funds holding IMRX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OCM

Occam Crest Management Darien, Connecticut $165M AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PNC Financial Services Group's IMRX Position: Q1 2026 in Review

PNC Financial Services Group held its Immuneering (IMRX) position steady in Q1 2026 at 20,000 shares worth $105K. The position accounts for ﹤0.01% of the portfolio, ranked #2783.

PNC Financial Services Group first reported a position in IMRX in Q3 2023 and has held it in 11 quarters since. The position peaked at $154K in Q3 2023. 95 funds tracked by Wall St. Rank hold IMRX as of Q1 2026.

PNC Financial Services Group held 20,000 shares of Immuneering worth $105K as of Q1 2026.
PNC Financial Services Group left its Immuneering share count unchanged in Q1 2026.
Immuneering made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #2783 holding.
PNC Financial Services Group first reported a position in Immuneering in Q3 2023 and has held it in 11 quarters since.
PNC Financial Services Group's Immuneering position peaked at $154K in Q3 2023.
95 funds tracked by Wall St. Rank held Immuneering as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.